Transforming growth factor-b1 gene+869T/C, but not +915G/C polymorphism is associated with essential hypertension in a Chinese patient cohort

Molecular Biology Reports

Volumn 39, Issue 5, 2012, Pages 6107-6112

  Xi, Bo ^a   Wang, Qijuan ^a   Pan, Haiyan ^b  

^a SHANDONG UNIVERSITY   (China)

^b GUANGDONG MEDICAL UNIVERSITY   (China)

Author keywords

Chinese; Hypertension; Meta analysis; Polymorphism; TGF 1

Indexed keywords

CYTIDINE; GUANOSINE; THYMIDINE; TRANSFORMING GROWTH FACTOR BETA1; TGFB1 PROTEIN, HUMAN;

ARTICLE; CHINESE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; GENE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SCREENING; GENETIC SUSCEPTIBILITY; HUMAN; MAJOR CLINICAL STUDY; RISK ASSESSMENT; SAMPLE SIZE; TRANSFORMING GROWTH FACTOR BETA1 GENE; ASIAN; CHINA; COHORT ANALYSIS; CONFIDENCE INTERVAL; GENETIC PREDISPOSITION; GENETICS; HYPERTENSION; META ANALYSIS; PUBLISHING; RISK; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; COHORT STUDIES; CONFIDENCE INTERVALS; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERTENSION; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84863768102     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-011-1427-5     Document Type: Article

References (39)

1. Lawes CM, Vander Hoorn S, Rodgers A (2008) Global burden of blood-pressure-related disease, 2001. Lancet 371:1513-1518
2. Whelton PK, He J, Appel LJ et al (2002) Primary prevention of hypertension: clinical and public health advisory from The National High Blood Pressure Education Program. JAMA 288:1882-1888
3. Williams SS (2007) Advances in genetic hypertension. Curr Opin Pediatr 19:192-198
4. Luft FC (2001) Twins in cardiovascular genetic research. Hypertension 37:350-356
5. Cambien F, Ricard S, Troesch A et al (1996) Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Témoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28:881-887
6. Roberts AB, McCune BK, Sporn MB (1992) TGF-beta: regulation of extracellular matrix. Kidney Int 41:557-559
7. Lijnen PJ, Petrov VV, Fagard RH (2003) Association between transforming growth factor-beta and hypertension. Am J Hypertens 16:604-611
8. Li B, Khanna A, Sharma V et al (1999) TGF-beta1 DNA polymorphisms, protein levels, and blood pressure. Hypertension 33:271-275
9. Li YY (2011) Transforming growth factor β1 +869T/C gene polymorphism and essential hypertension: a meta-analysis involving 2,708 participants in the Chinese population. Intern Med 50:1089-1092
10. Niu W (2011) Evaluation of transforming growth factor Beta-1 gene 869T/C polymorphism with hypertension: a meta-analysis. Int J Hypertens 2011:934265
11. Wei Y, Li Z, Lan JS (2005) Association of polymorphisms of transforming growth factor-beta 1 gene with susceptibility to essential hypertension in Zhuang nationality of Guangxi province. J Fourth Mil Med Univ 26:341-344
12. Hu BC, Chu SL, Wang JG et al (2006) Single nucleotide polymorphisms of three candidate genes in essential hypertension. Chin J Intern Med 45:281-284
13. Tang Y (2006) The relationship between polymorphism of transforming growth factor beta-1 and hypertension in Han nationality of Hunan province. Master Dissertation of Central South University 1-35
14. Zhang QY, Dong H, Wang YY et al (2006) The serum level and the single nucleotide polymorphism of TGF-β1 in patients with essential hypertension and left ventricular hypertrophy. Chin J Geriatr 25:358-360
15. Wang YY (2007) Modulatory role of some gene in the process of hypertensive target organ lesion in patients with essential hypertension. Doctoral Dissertation of Ocean University of China 1-104
16. Wei CL, Wu YJ, Qiu Q et al (2007) Association between polymorphisms in TGF-β1 gene and essential hypertension. Chin J Gerontol 27:962-964
17. Zhang ZD, Chen LC, Zeng GL et al (2009) Study on the relationship between gene polymorphism of transforming growth factor-β1 and atrial fibrillation in patients with essential hypertension. J Clin Res 26:211-213
18. Zhao D, Hu QH, Deng FM et al (2010) Association of the TGFbeta1 gene polymorphisms and blood TGF-beta 1 level with essential hypertension in Kazakh Chinese. Chin J Med Genet 27:463-468
19. He F, Zhao D, Deng F et al (2010) Association of TGF-beta 1 gene polymorphisms in exon1 and blood levels with essential hypertension. Blood Press 19:225-233
20. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188
21. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
22. Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-1101
23. Egger M, Davey Smith G, Schneider M et al (1997) Bias in metaanalysis detected by a simple, graphical test. BMJ 315:629-634
24. Hu CB, Chu SL, Zhu DL (2003) Association of the transforming growth factor-β1 gene with hypertension. Chin J Hypertens 11:196-199
25. Dong H, Sun YB, Li P et al (2007) The serum level and the single nucleotide polymorphism of TGF-β1 in patients with essential hypertension and left ventricular hypertrophy. Shanxi Med J 36:684-687
26. Chen HS, Zhang QY, Wang YY (2007) The relationship between the gene polymorphism and serum level of TGF-β1 in patients and renal damage caused by essential hypertension. J Clin Intern Med 24:57-59
27. Tang RG, Wei YS, Huang ZH (2009) Association of the transforming growth factor-β1 +869T/C gene polymorphism and essential hypertension. Chin J Clin Lab Sci 27:270-271
28. Yang JF, Shi XP, Zhao D et al (2010) Relationship between the rs1800469 polymorphisms of TGF-β1 gene and essential hypertension in the Han of Xinjiang. J Shihezi Univ (Natural Science) 28:576-581
29. Shi XP, Yang JF, Zhong H et al (2010) SNaPshot detect association of genetic polymorphisms in transforming growth factor Beta-1 with hypertension in the Kazakh ethnicities of Xinjiang. Chin J Epidemiol 31:1072-1074
30. Yang JF, Shi XP, Zhao D et al (2010) Association of the tagging single nucleotide polymorphisms in transforming growth factor beta-1 gene with hypertension in the Han nationality population in Xinjiang. Chin J Cardiol 38:503-509
31. Shen C (2008) Association study of gene polymorphisms in TGFβ1 signal pathway with essential hypertension. Doctoral dissertation of Peking Union Medical College 1-79
32. Suthanthiran M, Li B, Song JO et al (2000) Transforming growth factor-beta 1 hyperexpression inAfrican-American hypertensives:A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci USA 97:3479-3484
33. Frossard PM, Gupta A, Pravica V et al (2002) A study of five human cytokine genes in human essential hypertension. Mol Immunol 38:969-976
34. Rivera MA, Echegaray M, Rankinen T et al (2001) TGF-beta(1) gene-race interactions for resting and exercise blood pressure in the HERITAGE Family Study. J Appl Physiol 91:1808-1813
35. Yamada Y, Fujisawa M, Ando F et al (2002) Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals. J Hum Genet 47:243-248
36. Ivanov VP, Solodilova MA, Polonnikov AV et al (2007) Arg25Pro polymorphismof transforming growth factor-beta1 and its role in the pathogenesis of essential hypertension in Russian population of the Central Chernozem Region. Bull Exp Biol Med 144:66-68
37. Du RF, Xiao CJ, Cavalli-Sforza LL (1997) Genetic distance between Chinese populations calculated on gene frequencies of 38 loci. Sci China C Life Sci 40:613-621
38. Chu JY, Huang W, Kuang SQ et al (1998) Genetic relationship of populations in China. Proc Natl Acad Sci USA 95:11763-11768
39. Ioannidis JP (2003) Genetic associations: false or true? Trends Mol Med 9:135-138